• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类垂体瘤中的视网膜母细胞瘤基因。

The retinoblastoma gene in human pituitary tumors.

作者信息

Cryns V L, Alexander J M, Klibanski A, Arnold A

机构信息

Endocrine Unit, Massachusetts General Hospital, Boston.

出版信息

J Clin Endocrinol Metab. 1993 Sep;77(3):644-6. doi: 10.1210/jcem.77.3.7690360.

DOI:10.1210/jcem.77.3.7690360
PMID:7690360
Abstract

Functional inactivation of the retinoblastoma (RB) tumor suppressor gene is important in the pathogenesis of many human tumors. Recently, the frequent occurrence of pituitary tumors was reported in mice genetically engineered to have one defective RB allele, a genetic background analogous to that of patients with familial retinoblastoma. The molecular pathogenesis of human pituitary tumors is largely unknown, and the potential role of RB gene inactivation in these neoplasms has not been examined. Consequently, we studied 20 human pituitary tumors (12 clinically nonfunctioning tumors, 4 somatotroph adenomas, 2 prolactinomas, and 2 corticotroph adenomas) for tumor-specific allelic loss of the RB gene using a highly informative polymorphic locus within the gene. Control leukocyte DNA samples from 18 of these 20 patients were heterozygous at this locus, permitting genetic evaluation of their paired tumor specimens. In contrast to the pituitary tumors in the mouse model, none of these 18 human tumors exhibited RB allelic loss. These findings indicate that RB gene inactivation probably does not play an important role in the pathogenesis of common types of human pituitary tumors.

摘要

视网膜母细胞瘤(RB)肿瘤抑制基因的功能失活在许多人类肿瘤的发病机制中具有重要意义。最近,据报道,在经过基因工程改造而具有一个缺陷RB等位基因的小鼠中频繁出现垂体肿瘤,这种遗传背景类似于家族性视网膜母细胞瘤患者。人类垂体肿瘤的分子发病机制在很大程度上尚不清楚,并且尚未研究RB基因失活在这些肿瘤中的潜在作用。因此,我们使用该基因内一个信息丰富的多态性位点,研究了20例人类垂体肿瘤(12例临床无功能肿瘤、4例生长激素腺瘤、2例催乳素瘤和2例促肾上腺皮质激素腺瘤)中RB基因的肿瘤特异性等位基因缺失情况。这20例患者中有18例的对照白细胞DNA样本在该位点是杂合的,从而能够对其配对的肿瘤标本进行遗传学评估。与小鼠模型中的垂体肿瘤不同,这18例人类肿瘤均未表现出RB等位基因缺失。这些发现表明,RB基因失活可能在常见类型的人类垂体肿瘤发病机制中不发挥重要作用。

相似文献

1
The retinoblastoma gene in human pituitary tumors.人类垂体瘤中的视网膜母细胞瘤基因。
J Clin Endocrinol Metab. 1993 Sep;77(3):644-6. doi: 10.1210/jcem.77.3.7690360.
2
Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus.人类垂体腺瘤在视网膜母细胞瘤基因位点未显示杂合性缺失。
J Clin Endocrinol Metab. 1994 Apr;78(4):922-7. doi: 10.1210/jcem.78.4.8157722.
3
Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.人垂体腺瘤表达内源性抑制素亚基和卵泡抑素信使核糖核酸。
J Clin Endocrinol Metab. 1995 Jan;80(1):147-52. doi: 10.1210/jcem.80.1.7829603.
4
Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.人催乳素瘤和生长激素瘤垂体腺瘤中Pit-1基因表达与D2受体基因表达相关。
J Clin Endocrinol Metab. 1996 Sep;81(9):3390-6. doi: 10.1210/jcem.81.9.8784102.
5
Ras mutations in human pituitary tumors.人类垂体肿瘤中的Ras突变。
J Clin Endocrinol Metab. 1992 Apr;74(4):914-9. doi: 10.1210/jcem.74.4.1312542.
6
Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.
Cancer Res. 1995 Apr 15;55(8):1613-6.
7
Molecular screening of pituitary adenomas for gene mutations and rearrangements.垂体腺瘤的基因突变和重排的分子筛查。
J Clin Endocrinol Metab. 1993 Jul;77(1):50-5. doi: 10.1210/jcem.77.1.8100831.
8
Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.甲状旁腺癌中视网膜母细胞瘤肿瘤抑制基因的缺失。
N Engl J Med. 1994 Mar 17;330(11):757-61. doi: 10.1056/NEJM199403173301105.
9
Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus.分泌促肾上腺皮质激素的人类垂体腺瘤在糖皮质激素受体基因位点常出现杂合性缺失。
J Clin Endocrinol Metab. 1998 Mar;83(3):917-21. doi: 10.1210/jcem.83.3.4648.
10
Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors.
Cancer. 1994 Jul 15;74(2):693-6. doi: 10.1002/1097-0142(19940715)74:2<693::aid-cncr2820740223>3.0.co;2-p.

引用本文的文献

1
Genetic models of Cushing's disease : From cells, in vivo transgenic models to human pituitary organoids.库欣病的遗传模型:从细胞、体内转基因模型到人类垂体类器官
Pituitary. 2025 Apr 5;28(2):47. doi: 10.1007/s11102-025-01516-1.
2
Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma.亚洲特有的 CDKN2B 3'UTR 变异与垂体腺瘤风险相关。
Mol Biol Rep. 2022 Nov;49(11):10339-10346. doi: 10.1007/s11033-022-07796-1. Epub 2022 Sep 12.
3
Recent Understanding and Future Directions of Recurrent Corticotroph Tumors.
复发性促肾上腺皮质细胞瘤的最新认识与未来方向。
Front Endocrinol (Lausanne). 2021 Apr 26;12:657382. doi: 10.3389/fendo.2021.657382. eCollection 2021.
4
Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?垂体瘤的基因组学和表观基因组学:病理学家需要了解什么?
Endocr Pathol. 2021 Mar;32(1):3-16. doi: 10.1007/s12022-021-09663-4. Epub 2021 Jan 12.
5
Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors , , , and in neuroendocrine tumors in mice.对小鼠神经内分泌肿瘤中肿瘤抑制因子、、、和靶向缺失的协同致瘤作用的遗传分析。
Oncotarget. 2020 Jul 14;11(28):2718-2739. doi: 10.18632/oncotarget.27660.
6
Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease.库欣病的细胞周期调节因子和谱系特异性治疗靶点
Front Endocrinol (Lausanne). 2018 Aug 10;9:444. doi: 10.3389/fendo.2018.00444. eCollection 2018.
7
The role of genetic and epigenetic changes in pituitary tumorigenesis.基因和表观遗传变化在垂体肿瘤发生中的作用。
Neurol Med Chir (Tokyo). 2014;54(12):943-57. doi: 10.2176/nmc.ra.2014-0184. Epub 2014 Nov 29.
8
The role of epigenetic modification in tumorigenesis and progression of pituitary adenomas: a systematic review of the literature.表观遗传修饰在垂体腺瘤发生和进展中的作用:文献系统综述。
PLoS One. 2013 Dec 18;8(12):e82619. doi: 10.1371/journal.pone.0082619. eCollection 2013.
9
Genomic approaches to problems in pituitary neoplasia.垂体瘤相关问题的基因组学研究方法。
Endocr Pathol. 2014 Sep;25(3):209-13. doi: 10.1007/s12022-013-9276-5.
10
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.散发性垂体腺瘤中肿瘤抑制基因的遗传和表观遗传突变。
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):16-33. doi: 10.1016/j.mce.2013.09.006. Epub 2013 Sep 11.